Use the Back button in your browser to see the other results of your search or to select another record.
Comparison of the effectiveness of extensor muscle strengthening exercise by itself, exercise with polydeoxyribonucleotide injection, and exercise with extracorporeal shockwave therapy in lateral epicondylitis: a randomized controlled trial |
Shim BJ, Seo E-M, Hwang J-T, Kim D-Y, Yang J-S, Seo S-J, Hong MS |
Clinics in Shoulder and Elbow 2021 Dec;24(4):231-238 |
clinical trial |
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
BACKGROUND: Extensor muscle strengthening exercises with counterforce braces (EX) is a conventional conservative treatment for lateral epicondylitis (LE) of the elbow. In addition, polydeoxyribonucleotide (PDRN) or extracorporeal shockwave therapy (ESWT) has been recently used for LE. METHODS: Sixty-three patients with chronic LE participated in this study and randomly allocated in three groups (G1 EX, G2 EX plus PDRN injection, and G3 EX+ESWT). All of the three groups were taught to perform EX at the first out-patient department (OPD) visit. Group 2 was injected with 3 mL PDRN (5.625 mg/3 mL), while group 3 received ESWT at the first OPD visit. Visual analog scale pain score, Mayo elbow performance score (MEPS), and ultrasonographic examination were checked before, 6 weeks, and 12 weeks after the treatments. RESULTS: Overall functional scores and ultrasonographic findings in all three groups improved after treatment. The mean MEPS in group 2 improved more than groups 1 and 3 at 6 weeks (G1 56.9 > 62.4; G2 54.3 > 65.0; G3 55.7 > 62.6), and more than group 1 at 12 weeks (G1 56.9 > 67.9; G2 54.3 > 73.6). The mean common extensor tendon depth (CETD) on ultrasonography in group 2 increased more than groups 1 and 3 at 6 and 12 weeks (6 weeks G1 0.385 > 0.386; G2 0.332 > 0.392; G3 0.334 > 0.357; 12 weeks G1 0.385 > 0.409; G2 0.332 > 0.438; G3 0.334 > 0.405 cm). CONCLUSIONS: PDRN injections combined with EX exhibited a greater improvement in mean MEPS and mean CETD compared to EX only or EX combined with ESWT for LE within the 12 weeks follow-up.
|